- Joined
- Nov 30, 2009
- Messages
- 4,260
- Reaction score
- 9,570
In the moral injury thread, the claim was made that psychiatry must concern itself with "diseased brains" and biomedical interventions to maintain its moral authority as a medical specialty. The implication was that wider social and psychological forces that shape our patient's experience were of peripheral concern to psychiatry and psychiatrists. The claim was also that that the power, privilege, and even "prestige" that psychiatrists might enjoy was dependent on viewing mental illness as the product of disease brains. I would like to rebuff these claims.
The idea that psychiatry should focus on biomedical activities such as diagnoses and pharmacological and somatic treatments is not new. In the 1970s, the Neo-Kraepelinian school of psychiatry emerged as a direct response to the perceived existential threat posed to the profession by psychologists and social workers. Up until the 60s, psychotherapy and psychoanalysis in particular, was largely seen as a medical activity, exclusively practiced by psychiatrists with some notable exceptions. In fact, it was not until the late 1980s, following an anti-trust suit that non-physicians were routinely admitted to psychoanalytic institutes. The Neo-Kraepelian school held that psychiatry should abandon psychodynamic thinking and focus on making rigorous diagnoses, see more patients for shorter visits less frequently in line with our medical colleagues, and focus on psychopharmacological and somatic interventions. Diagnosis making and prescribing were seen as solely in the province of psychiatry, and promised to make psychiatry more respectable and immune from "threats" posed to its survival from other mental health professionals. Only they didn't.
In the intervening years, the popularity of psychiatry as a medical specialty plummeted with psychiatric residencies contracting and closing in droves. The subsistence of the profession became heavily reliant on international medical graduates. A whole generation of psychiatrists barely learned psychotherapy with many questioning whether psychiatrists still knew how to talk to patients. While the advent of SSRIs and atypical antipsychotics no doubt changed psychiatric practice, there have been no major advances in the efficacy of psychopharmacological agents since the 1950s. The Neo-Kraeplinian model aligned itself well with both the rise of managed care and the Regan era. Managed care saw psychiatrists as an expensive commodity who had no business providing psychotherapy and the "15 minute med check was born" while inpatient units, residential programs, and specialized psychotherapy oriented programs closed down. The Reagan administration found it politically expedient to support biological research into mental disorders and defunded any social and economic research that would reveal the human costs of monetarism.
The 90s was heralded as the "decade of the brain" and also launched the human genome project. Both promised to shine light on the dark secrets of mental illness and afford new hope in diagnosis and treatment. These promises too, failed. At the same time, psychiatry became wedded to the pharmaceutical industry and in the minds of both the public and congress, psychiatrists were seen as having been corrupted by big pharma. By the early 2000s, despite the widespread closure of psychiatric residency positions, recruitment into available positions was in dire straights and the public perception of the field was low. Even the then APA President Steven Sharfstein wondered aloud whether psychiatry had replaced the biopsychosocial model for the "bio-bio-bio model".
Meanwhile, psychiatrists were no longer the only ones who could diagnose - psychologists, social workers, masters' levels therapists, PAs, NPs, and nurses were all making DSM-based diagnoses as well. Even prescription privileges expanded to psychologists in some states and jurisdictions, with PAs and NPs in particular buoyed by the dearth of available psychiatrists. Psychiatrist reimbursement from insurance companies was in freefall, and without any semblance of mental health parity, denials for both inpatient and other levels of care became increasingly common. In aligning with the Neo-Kraepelinian approach, psychiatry had authored its own suicide note.
What relevance does this recent history lesson have for us today? Well, psychiatry is at its least compelling and popular when it narrowly focuses on biomedical aspects of what it means to suffer. Both medical students choosing a career and public at large don't buy it. The problems that psychiatry deals with are too expansive and varied and suffering too complex to be understood as merely the product of a diseased brain. In fact, the golden age of psychiatry (both in public perception and in terms of recruitment) was in the post-war period when psychiatry was heavily influenced by psychoanalysis. Basic psychoanalytically-informed therapies were seen as effective for the war neuroses of returning servicemen as well as holding allure for the Hollywood elite and intelligentsia. We are arguably experiencing a second "golden age" for psychiatry. It is an increasingly popular choice for medical students and the public and our elected officials have embraced the importance of mental health treatment. Five factors seem particularly relevant.
Firstly, the great recession created the economic conditions that increased the prevalence of mental illness. This also provided the impetus for the passage of mental health parity, and wider healthcare reform. The significant increase in the number of individuals with health insurance with mental health benefits, increased demand for psychiatric services. Secondly, the recession exacerbated existing inequalities, with white individuals without college degrees facing the brunt of the economic downturn, leading to a rise in "deaths of despair" such as opiate overdoses, alcohol-related deaths, and gun suicides. This change in demographics led to increased funding for addiction services and wider recognition of the intersection between mental illness and substance abuse. Thirdly, with limited advancements in psychiatric drug development and saturation in the pharmaceutical market, the industry significantly reduced its investments in psychiatric research. This led psychiatry to do some soul searching. Partly in response to the blowing cultural winds, the ACGME emphasized that training in certain psychotherapeutic modalities was core to our professional identity. Finally, the COVID-19 pandemic presented both challenges and opportunities in the realm of mental health. The pandemic caused widespread uncertainty and confinement, leading to an increase in mental health issues. However, telehealth became increasingly prevalent, providing greater access to treatment for those in need. In short, a narrowly remedicalized psychiatry that took hold in the 1980s almost killed the profession. In contrast, embracing mental health problems as influenced by social, political, and economic factors with multimodal interventions including but not limited to medications, created the conditions for psychiatry to thrive.
On a personal note, my non-psychiatric colleagues appreciate me most not because of my medical or psychiatric input but because of my expertise in psychosocial medicine. In my previous job I had numerous discussions and attended many meetings about complex patients to which I was invited because I could explain the puzzling behaviors in their patients in a way that made sense, validated the teams most primitive feelings, and led to concrete action. I was also frequently sought out to consult on complex ethical and risk management dilemmas. There will always be a place for physicians who understand and integrate the biomedical, psychological, sociocultural, ethical and medicolegal dimensions of care. Psychiatrists can fill that role. Or we can attempt to be a simulacrum of a stereotypical physician and condemn the field to obsolescence.
The idea that psychiatry should focus on biomedical activities such as diagnoses and pharmacological and somatic treatments is not new. In the 1970s, the Neo-Kraepelinian school of psychiatry emerged as a direct response to the perceived existential threat posed to the profession by psychologists and social workers. Up until the 60s, psychotherapy and psychoanalysis in particular, was largely seen as a medical activity, exclusively practiced by psychiatrists with some notable exceptions. In fact, it was not until the late 1980s, following an anti-trust suit that non-physicians were routinely admitted to psychoanalytic institutes. The Neo-Kraepelian school held that psychiatry should abandon psychodynamic thinking and focus on making rigorous diagnoses, see more patients for shorter visits less frequently in line with our medical colleagues, and focus on psychopharmacological and somatic interventions. Diagnosis making and prescribing were seen as solely in the province of psychiatry, and promised to make psychiatry more respectable and immune from "threats" posed to its survival from other mental health professionals. Only they didn't.
In the intervening years, the popularity of psychiatry as a medical specialty plummeted with psychiatric residencies contracting and closing in droves. The subsistence of the profession became heavily reliant on international medical graduates. A whole generation of psychiatrists barely learned psychotherapy with many questioning whether psychiatrists still knew how to talk to patients. While the advent of SSRIs and atypical antipsychotics no doubt changed psychiatric practice, there have been no major advances in the efficacy of psychopharmacological agents since the 1950s. The Neo-Kraeplinian model aligned itself well with both the rise of managed care and the Regan era. Managed care saw psychiatrists as an expensive commodity who had no business providing psychotherapy and the "15 minute med check was born" while inpatient units, residential programs, and specialized psychotherapy oriented programs closed down. The Reagan administration found it politically expedient to support biological research into mental disorders and defunded any social and economic research that would reveal the human costs of monetarism.
The 90s was heralded as the "decade of the brain" and also launched the human genome project. Both promised to shine light on the dark secrets of mental illness and afford new hope in diagnosis and treatment. These promises too, failed. At the same time, psychiatry became wedded to the pharmaceutical industry and in the minds of both the public and congress, psychiatrists were seen as having been corrupted by big pharma. By the early 2000s, despite the widespread closure of psychiatric residency positions, recruitment into available positions was in dire straights and the public perception of the field was low. Even the then APA President Steven Sharfstein wondered aloud whether psychiatry had replaced the biopsychosocial model for the "bio-bio-bio model".
Meanwhile, psychiatrists were no longer the only ones who could diagnose - psychologists, social workers, masters' levels therapists, PAs, NPs, and nurses were all making DSM-based diagnoses as well. Even prescription privileges expanded to psychologists in some states and jurisdictions, with PAs and NPs in particular buoyed by the dearth of available psychiatrists. Psychiatrist reimbursement from insurance companies was in freefall, and without any semblance of mental health parity, denials for both inpatient and other levels of care became increasingly common. In aligning with the Neo-Kraepelinian approach, psychiatry had authored its own suicide note.
What relevance does this recent history lesson have for us today? Well, psychiatry is at its least compelling and popular when it narrowly focuses on biomedical aspects of what it means to suffer. Both medical students choosing a career and public at large don't buy it. The problems that psychiatry deals with are too expansive and varied and suffering too complex to be understood as merely the product of a diseased brain. In fact, the golden age of psychiatry (both in public perception and in terms of recruitment) was in the post-war period when psychiatry was heavily influenced by psychoanalysis. Basic psychoanalytically-informed therapies were seen as effective for the war neuroses of returning servicemen as well as holding allure for the Hollywood elite and intelligentsia. We are arguably experiencing a second "golden age" for psychiatry. It is an increasingly popular choice for medical students and the public and our elected officials have embraced the importance of mental health treatment. Five factors seem particularly relevant.
Firstly, the great recession created the economic conditions that increased the prevalence of mental illness. This also provided the impetus for the passage of mental health parity, and wider healthcare reform. The significant increase in the number of individuals with health insurance with mental health benefits, increased demand for psychiatric services. Secondly, the recession exacerbated existing inequalities, with white individuals without college degrees facing the brunt of the economic downturn, leading to a rise in "deaths of despair" such as opiate overdoses, alcohol-related deaths, and gun suicides. This change in demographics led to increased funding for addiction services and wider recognition of the intersection between mental illness and substance abuse. Thirdly, with limited advancements in psychiatric drug development and saturation in the pharmaceutical market, the industry significantly reduced its investments in psychiatric research. This led psychiatry to do some soul searching. Partly in response to the blowing cultural winds, the ACGME emphasized that training in certain psychotherapeutic modalities was core to our professional identity. Finally, the COVID-19 pandemic presented both challenges and opportunities in the realm of mental health. The pandemic caused widespread uncertainty and confinement, leading to an increase in mental health issues. However, telehealth became increasingly prevalent, providing greater access to treatment for those in need. In short, a narrowly remedicalized psychiatry that took hold in the 1980s almost killed the profession. In contrast, embracing mental health problems as influenced by social, political, and economic factors with multimodal interventions including but not limited to medications, created the conditions for psychiatry to thrive.
On a personal note, my non-psychiatric colleagues appreciate me most not because of my medical or psychiatric input but because of my expertise in psychosocial medicine. In my previous job I had numerous discussions and attended many meetings about complex patients to which I was invited because I could explain the puzzling behaviors in their patients in a way that made sense, validated the teams most primitive feelings, and led to concrete action. I was also frequently sought out to consult on complex ethical and risk management dilemmas. There will always be a place for physicians who understand and integrate the biomedical, psychological, sociocultural, ethical and medicolegal dimensions of care. Psychiatrists can fill that role. Or we can attempt to be a simulacrum of a stereotypical physician and condemn the field to obsolescence.